Multi Medika Internasional
PT Multi Medika Internasional Tbk engages in the distribution of disposable health care and personal care products in Indonesia. The company offers face masks, hazmat suits, surgical gowns, antigen kits, oximeter, AirPatch Aromatheraphy, shoe covers, and hair caps. It also provides food and beverage products. The company was founded in 2020 and is headquartered in Jakarta Barat, Indonesia. PT Mul… Read more
Multi Medika Internasional (MMIX) - Total Assets
Latest total assets as of December 2024: Rp407.82 Billion IDR
Based on the latest financial reports, Multi Medika Internasional (MMIX) holds total assets worth Rp407.82 Billion IDR as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Multi Medika Internasional - Total Assets Trend (2020–2024)
This chart illustrates how Multi Medika Internasional’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Multi Medika Internasional - Asset Composition Analysis
Current Asset Composition (December 2024)
Multi Medika Internasional's total assets of Rp407.82 Billion consist of 76.2% current assets and 23.8% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp3.44 Billion | 0.0% |
| Accounts Receivable | Rp62.57 Billion | 15.3% |
| Inventory | Rp185.53 Billion | 45.5% |
| Property, Plant & Equipment | Rp91.53 Billion | 22.4% |
| Intangible Assets | Rp3.58 Billion | 0.9% |
| Goodwill | Rp0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Multi Medika Internasional's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Multi Medika Internasional's current assets represent 76.2% of total assets in 2024, a decrease from 100.0% in 2020.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 7.4% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 45.5% of total assets.
Multi Medika Internasional Competitors by Total Assets
Key competitors of Multi Medika Internasional based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
Multi Medika Internasional - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Multi Medika Internasional generates 0.47x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Multi Medika Internasional generates $ 0.30 in net profit.
Multi Medika Internasional - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.38 | 3.24 | 6.49 |
| Quick Ratio | 0.56 | 1.98 | 4.49 |
| Cash Ratio | 0.02 | 0.59 | 1.81 |
| Working Capital | Rp86.26 Billion | Rp 163.37 Billion | Rp 157.87 Billion |
Multi Medika Internasional - Advanced Valuation Insights
This section examines the relationship between Multi Medika Internasional's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 25.3% |
| Total Assets | Rp407.82 Billion |
| Market Capitalization | $15.50 Million USD |
Valuation Analysis
Below Book Valuation: The market values Multi Medika Internasional's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Multi Medika Internasional's assets grew by 25.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Multi Medika Internasional (2020–2024)
The table below shows the annual total assets of Multi Medika Internasional from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp407.82 Billion | +25.31% |
| 2023-12-31 | Rp325.45 Billion | +65.31% |
| 2022-12-31 | Rp196.87 Billion | +80.17% |
| 2021-12-31 | Rp109.27 Billion | +3262.41% |
| 2020-12-31 | Rp3.25 Billion | -- |